ArticleTuberculosis and respiratory diseases2025

KEAP1-NRF2 Pathway as a Novel Therapeutic Target for EGFR-Mutant Non-small Cell Lung Cancer.

Jae-Sun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.